Increased platelet and microparticle activation in HIV infection: Upregulation of P-selectin and tissue factor expression

Journal of Acquired Immune Deficiency Syndromes

Volumn 59, Issue 4, 2012, Pages 340-346

  Mayne, Elizabeth ^a   Funderburg, Nicholas T ^b   Sieg, Scott F ^b   Asaad, Robert ^b   Kalinowska, Magdalena ^b   Rodriguez, Benigno ^b   Schmaier, Alvin H ^b   Stevens, Wendy ^a   Lederman, Michael M ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

HIV 1; Immune activation; Platelets; Tissue factor

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN; PADGEM PROTEIN; THROMBOPLASTIN;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; MALE; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE ACTIVATION; UPREGULATION;

ADULT; AGED; ANTIGENS, CD14; ANTIGENS, CD38; BLOOD PLATELETS; CD4 LYMPHOCYTE COUNT; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HLA-DR ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; P-SELECTIN; PLATELET ACTIVATION; THROMBOPLASTIN; UP-REGULATION; YOUNG ADULT;

EID: 84859753760     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182439355     Document Type: Article

References (44)

1. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med. 2008;359:938-949.
2. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482-2494.
3. Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov. 2010;9:154-169.
4. Panes O, Matus V, Saez CG, et al. Human platelets synthesize and express functional tissue factor. Blood. 2007;109:5242-5250. (Pubitemid 46890544)
5. Jude B, Zawadzki C, Susen S, et al. Relevance of tissue factor in cardiovascular disease. Arch Mal Coeur Vaiss. 2005;98:667-671.
6. Klintman D, Li X, Thorlacius H. Important role of P-selectin for leukocyte recruitment, hepatocellular injury, and apoptosis in endotoxemic mice. Clin Diagn Lab Immunol. 2004;11:56-62. (Pubitemid 38090652)
7. Mangell P, Mihaescu A, Wang Y, et al. Critical role of P-selectindependent leukocyte recruitment in endotoxin-induced intestinal barrier dysfunction in mice. Inflamm Res. 2007;56:189-194. (Pubitemid 46985838)
8. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
9. Norman KE, Katopodis AG, Thoma G, et al. P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo. Blood. 2000;96: 3585-3591.
10. Maly M, Vojacek J, Hrabos V, et al. Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome. Physiol Res. 2003;52:719-728. (Pubitemid 38090101)
11. d'Arminio A, Sabin CA, Phillips AN, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS. 2004;18:1811-1817.
12. Kaplan RC, Kingsley LA, Gange SJ, et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS. 2008;22:1615-1624.
13. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med.2008;5:e203.
14. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373-384.
15. Funderburg N, Luciano AA, Jiang W, et al. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One. 2008;3:e1915.
16. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371. (Pubitemid 44924494)
17. Jiang W, Lederman MM, Hunt P, et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis. 2009;199:1177-1185.
18. Funderburg NT, Mayne E, Sieg SF, et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. Blood. 2010;115:161-167.
19. Andonegui G, Kerfoot SM, McNagny K, et al. Platelets express functional Toll-like receptor-4. Blood. 2005;106:2417-2423. (Pubitemid 41510815)
20. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179:859-870. (Pubitemid 29159331)
21. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203: 780-790.
22. Mangili A, Gerrior J, Tang AM, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis. 2006;43: 1482-1489. (Pubitemid 44845654)
23. Mooser V. Atherosclerosis and HIV in the highly active antiretroviral therapy era: towards an epidemic of cardiovascular disease? AIDS. 2003; 17:S65-S69. (Pubitemid 36667782)
24. Periard D, Cavassini M, Taffe P, et al. High prevalence of peripheral arterial disease in HIV-infected persons. Clin Infect Dis. 2008;46:761-767. (Pubitemid 351321563)
25. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood. 2004;104:942-947. (Pubitemid 39038012)
26. Liu Z, Cumberland WG, Hultin LE, et al. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIVdisease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:83-92.
27. Majluf-Cruz A, Silva-Estrada M, Sanchez-Barboza R, et al. Venous thrombosis among patients with AIDS. Clin Appl Thromb Hemost. 2004;10:19-25. (Pubitemid 38543713)
28. Crum-Cianflone NF, Weekes J, Bavaro M. Thromboses among HIVinfected patients during the highly active antiretroviral therapy era. AIDS Patient Care STDS. 2008;22:771-778.
29. Marchetti G, Bellistri GM, Borghi E, et al. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIVinfected patients on long-term highly active antiretroviral therapy. AIDS. 2008;22:2035-2038.
30. Hashimoto K, Jayachandran M, Owen WG, et al. Aggregation and microparticle production through Toll-like receptor 4 activation in platelets from recently menopausal women. J Cardiovasc Pharmacol. 2009;54: 57-62.
31. Wickenhauser C, Schmitz B, Baldus SE, et al. Selectins (CD62L, CD62P) and megakaryocytic glycoproteins (CD41a, CD42b) mediate megakaryocyte-fibroblast interactions in human bone marrow. Leuk Res. 2000;24:1013-1021.
32. Biro E, Sturk-Maquelin KN, Vogel GM, et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost. 2003;1:2561-2568.
33. Joop K, Berckmans RJ, Nieuwland R, et al. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost. 2001;85:810-820. (Pubitemid 32421813)
34. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95:930-935. (Pubitemid 30063043)
35. Calza L, Pocaterra D, Pavoni M, et al. Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls. J Acquir Immune Defic Syndr. 2009; 50:430-432.
36. Holme PA, Muller F, Solum NO, et al. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J. 1998;12:79-89.
37. Chong BH, Murray B, Berndt MC, et al. Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood. 1994;83:1535-1541. (Pubitemid 24081566)
38. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005;3:1590-1596. (Pubitemid 41716543)
39. Chen D, Giannopoulos K, Shiels PG, et al. Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium. Blood. 2004;104:1344-1349. (Pubitemid 39166509)
40. Choudhury A, Chung I, Blann AD, et al. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm. J Am Coll Cardiol. 2007;49:1957-1964. (Pubitemid 46695928)
41. Choudhury A, Chung I, Panja N, et al. Soluble CD40 ligand, platelet surface CD40 ligand, and total platelet CD40 ligand in atrial fibrillation: relationship to soluble P-selectin, stroke risk factors, and risk factor intervention. Chest. 2008;134:574-581.
42. Wang HB, Wang JT, Zhang L, et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol. 2007;8:882-892. (Pubitemid 47099040)
43. Kitchens RL, Thompson PA. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res. 2005;11:225-229. (Pubitemid 41358857)
44. Bas S, Gauthier BR, Spenato U, et al. CD14 is an acute-phase protein. J Immunol. 2004;172:4470-4479. (Pubitemid 38375263)